Education
About Us
Working with TipRanks
Follow Us
Kuros Biosciences (CH:KURN)
:KURN
KURN Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF4.61 - CHF32.00
Previous CloseN/A
Volume98.33K
Average Volume (3M)N/A
Market Cap
CHF681.46M
Enterprise ValueCHF430.56M
Total Cash (Recent Filing)CHF20.80M
Total Debt (Recent Filing)CHF2.39M
Price to Earnings (P/E)―
Beta1.11
Next Earnings
Mar 11, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding37,960,377
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Kuros Biosciences News
PremiumCompany Announcements
Kuros Biosciences Reports Strong Revenue Growth in 2024
PremiumCompany Announcements
Kuros Biosciences Achieves Record Growth and Strategic Expansion in 2024---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.02% Mutual Funds
― Other Institutional Investors
98.47% Public Companies and
Individual Investors
KURN FAQ
What was Kuros Biosciences ’s price range in the past 12 months?
Kuros Biosciences lowest stock price was CHF4.61 and its highest was CHF32.00 in the past 12 months.
What is Kuros Biosciences ’s market cap?
Kuros Biosciences ’s market cap is CHF681.46M.
When is Kuros Biosciences ’s upcoming earnings report date?
Kuros Biosciences ’s upcoming earnings report date is Mar 11, 2025 which is yesterday.
How were Kuros Biosciences ’s earnings last quarter?
Kuros Biosciences released its earnings results on Aug 08, 2024. The company reported -CHF0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -CHF0.006.
Is Kuros Biosciences overvalued?
According to Wall Street analysts Kuros Biosciences ’s price is currently Overvalued.
Does Kuros Biosciences pay dividends?
Kuros Biosciences does not currently pay dividends.
What is Kuros Biosciences ’s EPS estimate?
Kuros Biosciences ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kuros Biosciences have?
Kuros Biosciences has 37,960,377 shares outstanding.
What happened to Kuros Biosciences ’s price movement after its last earnings report?
Kuros Biosciences reported an EPS of -CHF0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.839%.
Which hedge fund is a major shareholder of Kuros Biosciences ?
Currently, no hedge funds are holding shares in CH:KURN
---
Company Description
Kuros Biosciences
Kuros Biosciences Ltd is a biotechnology company that focuses on the discovery, development and prospective commercialization of a new class of bio-pharmaceutical products for use in the treatment and prevention of chronic diseases. The company is also developing a family of bone healing products to address indications in trauma, and spine as well as sealants which provides reliable closure of tissue membranes to ensure functional integrity after surgery or trauma. The pipeline products of the company are Synthetic Orthobiologics, Fibrin Orthobiologics, and Sealants. The majority of the company's revenue comes from the United States.
---
---